521 Dirksen Senate Office Building
Washington, DC 20510
Senate Passes Hagan Legislation as Part of FDA Overhaul Bill
Thursday, May 24, 2012
U.S. Senator Kay R. Hagan (NC) today praised passage of the bipartisan Food and Drug Administration Safety and Innovation Act. Central to this FDA overhaul bill are key provisions of the TREAT Act, or the Transforming the Regulatory Environment to Accelerate Access to Treatments Act, which Hagan introduced in February. The FDA Safety and Innovation Act passed the Senate by a vote of 96 to 1.